The Clorox Company $CLX Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH cut its holdings in shares of The Clorox Company (NYSE:CLX) by 3.3% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 128,924 shares of the company’s stock after selling 4,337 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Clorox were worth $15,480,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CLX. Simplicity Wealth LLC grew its holdings in Clorox by 157.3% during the second quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock worth $2,199,000 after acquiring an additional 11,198 shares during the period. Raymond James Financial Inc. boosted its position in Clorox by 15.6% in the 1st quarter. Raymond James Financial Inc. now owns 269,926 shares of the company’s stock worth $39,747,000 after purchasing an additional 36,352 shares in the last quarter. Nuance Investments LLC grew its stake in shares of Clorox by 182.5% during the 2nd quarter. Nuance Investments LLC now owns 848,106 shares of the company’s stock worth $101,832,000 after purchasing an additional 547,839 shares during the period. Vise Technologies Inc. purchased a new position in shares of Clorox during the 2nd quarter valued at approximately $328,000. Finally, Nordea Investment Management AB lifted its stake in shares of Clorox by 16.3% in the 2nd quarter. Nordea Investment Management AB now owns 484,352 shares of the company’s stock valued at $57,827,000 after purchasing an additional 68,026 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Performance

NYSE CLX opened at $100.10 on Wednesday. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The stock’s 50 day simple moving average is $116.67 and its 200-day simple moving average is $122.95. The company has a market cap of $12.21 billion, a PE ratio of 15.35, a price-to-earnings-growth ratio of 0.92 and a beta of 0.52. The Clorox Company has a 1-year low of $99.63 and a 1-year high of $171.37.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. During the same quarter last year, the firm posted $1.86 EPS. The firm’s revenue for the quarter was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, equities research analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be paid a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a yield of 5.0%. The ex-dividend date of this dividend is Wednesday, January 28th. Clorox’s dividend payout ratio is currently 77.86%.

Analysts Set New Price Targets

Several analysts recently commented on CLX shares. BNP Paribas Exane dropped their price target on shares of Clorox from $110.00 to $103.00 and set an “underperform” rating on the stock in a research report on Tuesday, November 4th. Jefferies Financial Group restated a “buy” rating and set a $152.00 target price on shares of Clorox in a research report on Tuesday, November 4th. The Goldman Sachs Group reduced their price target on Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a report on Wednesday, October 1st. JPMorgan Chase & Co. lowered their price target on Clorox from $127.00 to $120.00 and set a “neutral” rating on the stock in a research report on Tuesday, November 4th. Finally, Citigroup reduced their target price on Clorox from $130.00 to $120.00 and set a “neutral” rating for the company in a research note on Tuesday, November 4th. One equities research analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and five have issued a Sell rating to the stock. According to data from MarketBeat.com, Clorox has an average rating of “Reduce” and a consensus target price of $125.69.

Insider Buying and Selling

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the transaction, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at $6,711,475.38. This trade represents a 21.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.63% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.